Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Exp Gerontol. 2018 Feb 24;106:116–124. doi: 10.1016/j.exger.2018.02.023

Table 5. Prevalence of sarcopenia in current study cohorts.

“Sarcopenia” criterion
EWGSOP/IWGS Baumgartner
Criteria
(Baumgartner et al., 1998)		 Society of
Sarcopenia,
Cachexia, and
Wasting
Disorders		 Foundation of
NIH
Sarcopenia
Project
Males % SMI < 7.25 % SMI
2SD < 20–30 y
(7.65)		 % SMI
2SD < 20–39 y
(7.43)		 % ALM/
BMI < 0.789
25M 0.0 0.0 0.0 0.0
37M 0.0 4.4 2.2 0.0
61M 0.0 13.0 0.0 4.3
72M 17.6 35.3 23.5 11.8
Females % SMI < 5.67 % SMI
2SD < 20–30 y
(4.89)		 % SMI
2SD < 20–39 y
(5.06)		 % ALM/
BMI < 0.512
25F 7.7 3.8 3.8 0.0
37F 8.8 0.0 0.0 0.0
61F 19.4 0.0 0.0 0.0
72F 25.0 7.1 10.7 0.0

EWGSOP: European Working Group on Sarcopenia in Older People; IWGS: Internationaln Working Group on Sarcopenia; SMI: skeletal muscle index (kg/m2); ALM: appendicular lean mass (kg); BMI: body mass index (kg/m2).